GSK
GlaxoSmithKline PLC ADRNYSE
Healthcare • Drug Manufacturers - General
Factor tilt: Large-Cap Blend
$50.33-0.16%
Close Nov 6, 2026
- Market cap
- $100.8B
- 1 month
- +8.1%
- 3 months
- -3.5%
- 1 year
- +7.8%
- 52-week range
- $46.11$61.18
- Dividend, last 12 mo
- $1.8233 · 3.62% yield
- Last ex-date
- Aug 14, 2026 · $0.4515
- Dividend growth
- 2+ years in a row
- Short interest
- 14.6M sharessettled Oct 15, 2026 · -1.5% since Sep 30, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier. Figures are in GBP, the currency GSK reports in.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Jul 28, 2026 | £8.4B | — | 73.1% | £481.0M | £435.0M |
| Mar 2026filed Apr 29, 2026 | £7.6B | +1.5% | 75.4% | £2.3B | £1.7B |
| Sep 2025filed Oct 28, 2025 | £8.5B | +6.7% | 73.6% | £2.6B | £2.0B |
| Mar 2025filed Apr 30, 2025 | £7.5B | +2.1% | 74.2% | £2.2B | £1.6B |
| Dec 2024filed Feb 5, 2025 | £8.1B | +0.8% | 68.5% | £696.0M | £414.0M |
| Sep 2024filed Oct 30, 2024 | £8.0B | -1.7% | 70.1% | £189.0M | -£58.0M |
| Jun 2024filed Jul 31, 2024 | £7.9B | — | 73.1% | £1.6B | £1.2B |
| Mar 2024filed May 1, 2024 | £7.4B | — | 73.2% | £1.5B | £1.0B |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched GSK. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
14,579,567 shares short
-217,549 shares (-1.5%) vs Sep 30, 2026
Share of float unavailable. Published Oct 26, 2026.
Settlement Sep 30, 2026
14,797,116 shares short
+145,033 shares (+1%) vs Sep 15, 2026
Share of float unavailable. Published Oct 9, 2026.
Settlement Sep 15, 2026
14,652,083 shares short
+1,105,471 shares (+8.2%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
13,546,612 shares short
-1,231,578 shares (-8.3%) vs Aug 14, 2026
0.3% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
14,778,190 shares short
+261,228 shares (+1.8%) vs Jul 31, 2026
0.4% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
14,516,962 shares short
+757,156 shares (+5.5%) vs Jul 15, 2026
0.4% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind GSK’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
USD 0.451826 per share
Ex-dividend date: Nov 13, 2026 (future recorded date)
Recorded pay date: Jan 7, 2027 (pending)
Cash dividend · Polygon event record
USD 0.45152 per share
Ex-dividend date: Aug 14, 2026
Recorded pay date: Oct 8, 2026 (past date)
Cash dividend · Polygon event record
USD 0.461074 per share
Ex-dividend date: May 15, 2026
Recorded pay date: Jul 9, 2026 (past date)
Cash dividend · Polygon event record
USD 0.477611 per share
Ex-dividend date: Feb 20, 2026
Recorded pay date: Apr 9, 2026 (past date)
Cash dividend · Polygon event record
USD 0.433113 per share
Ex-dividend date: Nov 14, 2025
Recorded pay date: Jan 8, 2026 (past date)
Cash dividend · Polygon event record
USD 0.42996 per share
Ex-dividend date: Aug 15, 2025
Recorded pay date: Oct 9, 2025 (past date)
Cash dividend · Polygon event record
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
2 for 1 · forward split
Effective Nov 12, 1991
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jan 27, 1986
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Feb 23, 1983
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
1 conflicting split date is omitted; the ratio could not be resolved.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if GSK is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
137 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Nov 3, 2026
Smart-money 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 0
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
1,051 filers reported a long position in GSK for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
64.3%
of the 346.6M shares 13-F filers reported
Moves vs Q1 2026
2 added8 trimmed
Net shares held
-8.8%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | FMR LLC | $3.4B · 65M shares | 65M | -4% |
| 2 | DODGE & COX | $2.5B · 48.2M shares | 48.2M | -17.8% |
| 3 | Fisher Asset Management, LLC | $1.9B · 35.7M shares | 35.7M | +3.5% |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | $1.3B · 25.2M shares | 25.2M | -0.1% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | $597.4M · 11.4M shares | 11.4M | -2.7% |
| 6 | JTC Employer Solutions Trustee Ltd | $450.3M · 8.6M shares | 8.6M | -5% |
| 7 | MORGAN STANLEY | $401.4M · 7.7M shares | 7.7M | -30.6% |
| 8 | ROYAL BANK OF CANADA | $397.8M · 7.6M shares | 7.6M | +1.1% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | $362.9M · 6.9M shares | 6.9M | -5.5% |
| 10 | ACADIAN ASSET MANAGEMENT LLC | $349.1M · 6.7M shares | 6.7M | -43.5% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of GSK file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 13, 2026 | DODGE & COX13G · passive · amended | 4.3%under 5% |
Get the Full Analysis for GSK
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.